Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q83827341)
Watch
English
Treatment of AML: resurrection for gemtuzumab ozogamicin?
scientific article published on 05 April 2012
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22482941
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22482941%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
title
Treatment of AML: resurrection for gemtuzumab ozogamicin?
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22482941
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22482941%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
author name string
Elihu Estey
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22482941
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22482941%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
language of work or name
English
0 references
publication date
5 April 2012
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22482941
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22482941%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22482941
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22482941%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
volume
379
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22482941
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22482941%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
issue
9825
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22482941
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22482941%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
page(s)
1468-1469
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22482941
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22482941%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
cites work
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960534-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic advances in acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960534-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose daunorubicin in older patients with acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960534-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute myeloid leukemia stem cells and CD33-targeted immunotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960534-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960534-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960534-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960534-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960534-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960534-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(12)60534-0
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22482941
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22482941%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
PubMed publication ID
22482941
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22482941
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22482941%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit